CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse
Status:
Completed
Trial end date:
2002-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of CMA-676 in treating patients with acute
myeloid leukemia in first relapse.